Two agents deliver knockout punches to Ewing sarcoma

(Georgetown University Medical Center) When combined with an already FDA-approved chemotherapy, a novel agent developed by researchers at Georgetown Lombardi Comprehensive Cancer Center, appears to halt the ability of Ewing sarcoma to grow and progress.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news